Summit Partners completed the investment in RIS Rx.

Summit Partners, a private equity firm, completed the investment in RIS Rx, a healthcare technology company. Financial terms were not disclosed. “Every year, drug manufacturers spend billions on patient affordability programs, yet up to 20% of that support never reaches the patients it’s intended to help. We built RIS Rx to fix this broken system, applying automation, data and clinical expertise to stop GTN revenue leakage in real-time. Summit’s investment and strategic partnership will help us deepen our product capabilities, scale our team and expand our impact across the industry,” Gerard Rivera, RIS Rx CEO and Co-Founder.